T-cell cancer therapy holds promise, longer-term results await – Reuters
Reuters |
T–cell cancer therapy holds promise, longer-term results await
Reuters The new drug class, known as chimeric antigen receptor T–cell or CAR-T, involves a complicated process of extracting immune system T–cells from an individual patient, altering the cell DNA to sharpen their ability to spot and kill cancer cells, and … |
